Investor Relations

NYSE: TDOC +0.33 +0.55%
Volume: 627,429
20 minute delay August 21, 2019

At Teladoc Health, we are transforming how people access healthcare around the world

Teladoc Health is the global virtual care leader, helping millions of people resolve their healthcare needs with confidence.

We have unified the combined capabilities and global market presence of our award-winning consumer experience brands to create the only comprehensive virtual care solution capable of serving organizations and people everywhere.

Investor Events

Investor News

August 6, 2019
Teladoc Health to Participate in Upcoming Investor Conferences
PURCHASE, NY, Aug. 06, 2019 (GLOBE NEWSWIRE) - Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Jason Gorevic, chief executive officer, and Mala Murthy, chief financial officer, will participate in the following upcoming investor events: The Canaccord Genuity 39th Annual Growth Conference in Boston on Thursday, August 8, 2019, which will include a presentation at 10:00 a.m. EDT. The 2019 Wells Fargo Securities Healthcare Conference in Boston on Thursday, September 5, 2019, which will include a presentation at 8:35 a.m. EDT. A live audio webcast and replay of both presentations will be available at About Teladoc Health
A mission-driven organization, Teladoc Health, Inc. is successfully transforming how people access and experience healthcare, with a focus on high quality, lower costs, and improved outcomes around the world. The company’s award-winning, integrated...
Read More
July 31, 2019
Teladoc Health Reports Second Quarter 2019 Results
Year-over-year Q2 revenue grows 38% to $130.3 million and total visits increase 70% to 908,000 Year-over-year first half revenue grows 41% to $258.8 million and total visits increase 73% to 1,971,000 Issues 2019 third-quarter guidance and updates full-year expectations PURCHASE, NY, July 31, 2019 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the second quarter ending June 30, 2019. “The second quarter punctuated a strong first half of the year for Teladoc Health. Our robust engagement science strategies have allowed us to capitalize on the macro tailwinds we’re seeing globally to drive solid results across all of our markets and clinical specialties,” said Jason Gorevic, chief executive officer, Teladoc Health. “We built out our senior leadership team with two important additions during the quarter, and we made meaningful progress towards realizing the long-term benefits of our diversified growth strategy....
Read More

Get in touch today

Contact Teladoc Health Investor Relations

Bob East, Asher Dewhurst, Jordan Kohnstam

Westwicke Partners